The buzz around AI tools is hard to ignore, and the promises are even harder to miss. Still, many pharma companies remain cautious, as integrating a new AI solution is neither straightforward nor inexpensive. AI adoption is often weighed down by costs, complex legacy systems integrations, and compliance hurdles. When vendors layer on ambitious five-year implementation plans, taking the first step becomes a daunting challenge. Rebecca Greenberg, founder and CEO of DeepThink Analytics, shifts the conversation by asking pharma companies, ‘What’s the smallest, most meaningful step you can take right now?’ This is her first step to guide clients through digital transformation and AI implementation projects with a practical and feasible approach. Her strategy is use case driven, focusing on real-world scenarios, where AI or digital tools can offer immediate, tangible value, helping clients make progress without being overwhelmed by large-scale, abstract solutions. According to Greenberg, AI doesn’t need to transform a business’ entire operation overnight. Sometimes, the best place to start is with the everyday tasks that slow the teams down. Start small, and the momentum to drive change takes care of itself. “My clients are the experts in their world. My role is to help them rethink the systems they already know and navigate change without chaos. We don’t sell solutions—we co-create them,” says Greenberg. That’s why Greenberg’s method stands out. As a technology-agnostic, she understands many companies are already locked into AWS, Databricks, or legacy systems they can’t easily replace, while others simply lack the budget for sweeping, all-at-once AI rollouts. Her approach begins with a pragmatic assessment of the organization’s current assets, prioritizing efficiency over costly, complex solutions. This can involve leveraging in-house tools—such as using Copilot to draft L&D scripts—or initiating low-risk, high-value pilot projects. In some cases, it is as straightforward as organizing messy spreadsheets, where one person puts ‘Cape Canaveral, Florida’ in a single cell and someone else splits it across three columns. This step helps clients recognize how much of their digital transformation journey still lies ahead while gaining a clearer understanding of what true digital transformation entails. Small wins like these build trust and momentum. Once people see what’s possible, they’re more open to exploring larger-scale solutions that add more value. Greenberg achieves this by leading with the right questions — the kind that help clients surface the answers they had all along..

Every blood donation represents an opportunity to save a life. Moving it safely from donor to patient relies on precise coordination between donor centers and hospitals. But in many cases, the technology underpinning this process remains rooted in older, on-premise systems. These platforms were designed primarily for keeping records, rather than providing staff with real-time visibility into the status of each unit or its readiness for use. That limitation is felt daily. A blood product may be needed immediately in an emergency room or just as urgently to support a cell therapy protocol for a cancer patient. Staff need to know instantly whether the product is available, where it is in the testing process and how quickly it can be released. Organizations on disconnected databases rely on their teams to patch together information from various resources and often perform manual data updates. Blood Bank Computer Systems (BBCS) is changing the paradigm and replacing the need for these antiquated databases. BBCS has developed the ForLife Biologics Platform^®, a secure, cloud-hosted biologics management system, to combine donor management, manufacturing, inventory and distribution into one connected environment with robust, FDA-compliant software. “Staff can manage the lifecycle of critical blood products in real time, enabling hospitals and biologics organizations to act quickly and with greater confidence when patient care is on the line,” says Brian Forbis, CEO and President. “For providers, it offers peace of mind, knowing the verified source and status of each unit and that it’s ready for use the moment it’s needed.” The 3S of Biologics Management: Simple, Secure and Seamless Adaptability has always been at the heart of BBCS’s vision. Biologic centers can’t afford a system that only works for today’s products. They need one that evolves with medicine itself. That’s why ForLife^® was designed to manage both the blood products that keep hospitals running—plasma, platelets and red cells—and the cellular therapies that are reshaping tomorrow’s treatments. ForLife^® allows any type of biologic material to be collected while enforcing the rules specific to the type of donation..